VNOVOTCWholesale-Apparel, Piece Goods & NotionsFiscal year ends April 30
VitaNova Life Sciences Corp
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026
$4.50+0.50 (+12.50%)
Close on Oct 19, 2026
- Market cap
- $37.52M
- P/E (TTM)
- –
- Dividend yield
- –
VitaNova Life Sciences Corp revenue by segment
By business segment
| Revenue | TTM Q1 27 | TTM Q4 26 | TTM Q3 26 | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dietary Supplement Segment [Member] | $1.93M | $1.95M | $3.18M | $2.77M | $2.64M | $2.65M | – | – | – | – | 59.7% | -26.8% |
| Consulting Service Segment [Member] | – | – | $15.00K | $17.71K | $15.06K | $10.84K | – | – | – | – | – | – |
| Healthcare Segment [Member] | – | – | – | – | $2.64M | $2.65M | – | – | – | – | – | – |
| Operating income | TTM Q1 27 | TTM Q4 26 | TTM Q3 26 | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dietary Supplement Segment [Member] | $88.57K | $168.07K | $1.73M | $1.59M | $1.48M | $1.48M | – | – | – | – | -94.0% |
| Consulting Service Segment [Member] | – | – | -$530.32K | -$335.15K | -$261.49K | -$270.72K | – | – | – | – | – |
| Healthcare Segment [Member] | – | – | – | – | $1.48M | $1.48M | – | – | – | – | – |
By product or service
| Revenue | TTM Q1 27 | TTM Q4 26 | TTM Q3 26 | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sale Of Healthcare Products [Member] | – | – | $3.18M | $2.77M | $2.64M | $2.65M | – | – | – | – | – | – |
| Consulting Service Income [Member] | – | $15.00K | $15.00K | $17.71K | $15.06K | $10.84K | – | – | – | – | – | – |
By region
| Revenue | TTM Q1 27 | TTM Q4 26 | TTM Q3 26 | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hong Kong SAR China | – | $345.58K | $965.71K | $871.46K | $963.75K | $1.07M | $387.52K | $282.52K | $190.22K | $81.75K | – | – |
| Unites States Of America [Member] | – | $2.68M | $1.93M | $1.61M | $1.31M | $1.20M | $368.69K | $198.47K | $77.85K | $77.85K | – | – |
| China | – | $0 | – | – | – | $385.72K | – | – | – | $411.10K | – | – |
From the segment and revenue-disaggregation notes of VitaNova Life Sciences's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.